Drug profile · INN
cyclizine lactate
MAREZINE
cyclizine lactate (MAREZINE) is a histamine h1 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — cyclizine lactate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
cyclizine lactate (MAREZINE) is a histamine h1 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cyclizine lactate?
cyclizine lactate (MAREZINE) is a histamine h1 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cyclizine lactate?
MAREZINE is a marketed brand name for cyclizine lactate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cyclizine lactate?
cyclizine lactate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.